Peptide Research in Australia: TGA Regulations, Sourcing & Quality Guide 2026 Australia has a rapidly growing peptide research community, with strong academic institutions, a thriving biotech sector, and increasing interest in performance and longevity science. For Australian researchers, understanding the TGA (Therapeutic Goods Administration) regulatory framework and sourcing high-purity research compounds is essential. This guide […]
Author Archives: 汉普肽团队
Peptide Research in Canada: Legal Status, Sourcing & Quality Guide 2026 Canada is one of the fastest-growing markets for peptide research in North America. With a strong academic research community, growing biotech sector, and increasing interest in performance and longevity science, Canadian researchers are actively sourcing high-purity research peptides. This guide covers the legal status […]
China Peptide Supplier: UK Shipping, Quality Verification & Lab Research Guide 2026 China has emerged as a global hub for peptide manufacturing, offering researchers worldwide access to high-purity compounds at competitive prices. For UK researchers, sourcing from China-based suppliers like Hanpro Peptides provides significant advantages — wider product selection, competitive pricing, and direct access to […]
Buying Peptides in the UK: Purity Verification, COA & Shipping Guide 2026 Purchasing research peptides in the United Kingdom requires careful attention to quality, documentation, and logistics. Whether you are a university researcher, biotech professional, or independent laboratory investigator, this guide walks you through everything you need to know about buying peptides in the UK […]
Peptide Research in the UK: Legal Status, MHRA Guidelines & Sourcing Guide 2026 The United Kingdom is one of Europe’s largest markets for peptide research compounds. With a strong scientific community, growing biotech sector, and increasing interest in performance and longevity research, understanding the UK regulatory landscape is essential for researchers and suppliers alike. This […]
Follistatin: The Myostatin-Binding Peptide for Muscle Research Follistatin is a naturally occurring protein that binds and neutralizes activins and myostatin — key negative regulators of muscle mass. By inhibiting myostatin, follistatin supports muscle growth pathways, making it one of the most researched compounds in muscle biology and performance peptide science. This guide reviews its mechanism, […]
LL-37: The Antimicrobial Peptide for Immunity and Tissue Repair Research LL-37 is the only human cathelicidin antimicrobial peptide, a multifunctional immune molecule with direct antimicrobial activity and broad immunomodulatory, wound-healing, and anti-inflammatory effects. It is a cornerstone of innate immunity research and a rising star in tissue repair and regenerative peptide studies. This guide reviews […]
Tesofensine: The Triple Reuptake Inhibitor for Weight Loss Research Tesofensine is a novel monoamine reuptake inhibitor that targets serotonin, noradrenaline, and dopamine transporters simultaneously — a “triple reuptake inhibition” mechanism that produced some of the largest weight-loss effects observed in clinical trials. It reached phase 3 development for obesity before development paused, and it remains […]
Mazdutide (GLP-1/GCGR Dual Agonist): The Next-Generation Metabolic Peptide Guide Mazdutide is a once-weekly dual agonist of the glucagon-like peptide-1 (GLP-1) receptor and the glucagon receptor (GCGR), developed for obesity and metabolic dysfunction. By combining GLP-1’s appetite suppression with glucagon’s energy expenditure effects, mazdutide represents a distinct mechanism among next-generation metabolic peptides. This guide reviews its […]
Cagrilintide: The Amylin Analog for Weight Management Research Cagrilintide is a long-acting analog of amylin, a pancreatic hormone that regulates appetite and satiety, developed for weight management and metabolic research. As the GLP-1 receptor agonist landscape expands, amylin analogs like cagrilintide represent a complementary mechanism — studied alone and in combination with semaglutide (cagrilintide 2.4mg […]